[BDRX] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
29-Jun-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 0.00%
YoY- 2.92%
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 149 234 201 84 226 275 -
PBT -1,717 -1,928 -1,699 -1,695 -8,930 -2,626 -3,255 -10.10%
Tax 63 144 169 118 220 416 445 -27.78%
NP -1,654 -1,784 -1,531 -1,577 -8,710 -2,210 -2,810 -8.44%
Tax Rate - - - - - - - -
Total Cost 1,654 1,933 1,765 1,778 8,794 2,436 3,085 -9.85%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 -1,197.32 -654.06 -786.53 -10,369.05 -977.65 -1,023.68 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -5.04 -7.19 -124.33 0.00 0.00 0.00 0.00 -
EPS Diluted -5.04 -7.19 -124.33 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.